SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-19-010941
Filing Date
2019-01-17
Accepted
2019-01-17 06:56:59
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 d669959d424b5.htm 424B5 426467
2 GRAPHIC g669959g28r83.jpg GRAPHIC 42539
3 GRAPHIC g669959g78s42.jpg GRAPHIC 38623
4 GRAPHIC g669959g81t98.jpg GRAPHIC 25909
  Complete submission text file 0001193125-19-010941.txt   575325
Mailing Address 7555 GATEWAY BLVD. NEWARK CA 94560
Business Address 7555 GATEWAY BLVD. NEWARK CA 94560 510-742-3400
Revance Therapeutics, Inc. (Filer) CIK: 0001479290 (see all company filings)

IRS No.: 770551645 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-221911 | Film No.: 19530048
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1